Arnould T, Vankoningsloo S, Renard P, Houbion A, Ninane N, Demazy C, Remacle J, Raes M
Laboratoire de Biochimie et Biologie Cellulaire, University of Namur (FUNDP), 61 rue de Bruxelles, B-5000 Namur, Belgium.
EMBO J. 2002 Jan 15;21(1-2):53-63. doi: 10.1093/emboj/21.1.53.
We characterized a new signaling pathway leading to the activation of cAMP-responsive element-binding protein (CREB) in several cell lines affected by mitochondrial dysfunction. In vitro kinase assays, inhibitors of several kinase pathways and overexpression of a dominant-negative mutant for calcium/calmodulin kinase IV (CaMKIV), which blocks the activation of CREB, showed that CaMKIV is activated by a mitochondrial activity impairment. A high calcium concentration leading to the disruption of the protein interaction with protein phosphatase 2A explains CaMKIV activation in these conditions. Transcrip tionally active phosphorylated CREB was also found in a rho0 143B human osteosarcoma cell line and in a MERRF cybrid cell line mutated for tRNA(Lys) (A8344G). We also showed that phosphorylated CREB is involved in the proliferation defect induced by a mitochondrial dysfunction. Indeed, cell proliferation inhibition can be prevented by CaMKIV inhibition and CREB dominant-negative mutants. Finally, our data suggest that phosphorylated CREB recruits p53 tumor suppressor protein, modifies its transcriptional activity and increases the expression of p21(Waf1/Cip1), a p53-regulated cyclin-dependent kinase inhibitor.
我们在几种受线粒体功能障碍影响的细胞系中,鉴定出了一条导致环磷酸腺苷反应元件结合蛋白(CREB)激活的新信号通路。体外激酶分析、几种激酶通路的抑制剂以及钙/钙调蛋白激酶IV(CaMKIV)显性负突变体的过表达(该突变体可阻断CREB的激活)表明,CaMKIV是由线粒体活性损伤激活的。在这些条件下,高钙浓度导致蛋白质与蛋白磷酸酶2A的相互作用被破坏,从而解释了CaMKIV的激活。在rho0 143B人骨肉瘤细胞系和因tRNA(Lys)(A8344G)突变的MERRF杂交细胞系中也发现了具有转录活性的磷酸化CREB。我们还表明,磷酸化CREB参与了线粒体功能障碍诱导的增殖缺陷。事实上,通过抑制CaMKIV和使用CREB显性负突变体可以防止细胞增殖抑制。最后,我们的数据表明,磷酸化CREB招募p53肿瘤抑制蛋白,改变其转录活性,并增加p21(Waf1/Cip1)的表达,p21是一种p53调节的细胞周期蛋白依赖性激酶抑制剂。